IBDEI02C ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,616,1,5,0)
 ;;=5^323.9
 ;;^UTILITY(U,$J,358.3,616,2)
 ;;=^334231
 ;;^UTILITY(U,$J,358.3,617,0)
 ;;=351.0^^6^78^1
 ;;^UTILITY(U,$J,358.3,617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,617,1,4,0)
 ;;=4^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,617,1,5,0)
 ;;=5^351.0
 ;;^UTILITY(U,$J,358.3,617,2)
 ;;=^13238
 ;;^UTILITY(U,$J,358.3,618,0)
 ;;=V58.81^^6^79^20
 ;;^UTILITY(U,$J,358.3,618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,618,1,4,0)
 ;;=4^Vascular Cath Intro/Adj
 ;;^UTILITY(U,$J,358.3,618,1,5,0)
 ;;=5^V58.81
 ;;^UTILITY(U,$J,358.3,618,2)
 ;;=^303461
 ;;^UTILITY(U,$J,358.3,619,0)
 ;;=995.20^^6^79^3
 ;;^UTILITY(U,$J,358.3,619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,619,1,4,0)
 ;;=4^Adv Eff Drug,Unspec
 ;;^UTILITY(U,$J,358.3,619,1,5,0)
 ;;=5^995.20
 ;;^UTILITY(U,$J,358.3,619,2)
 ;;=^334208
 ;;^UTILITY(U,$J,358.3,620,0)
 ;;=V70.7^^6^79^9
 ;;^UTILITY(U,$J,358.3,620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,620,1,4,0)
 ;;=4^Exam in Clinical Trial
 ;;^UTILITY(U,$J,358.3,620,1,5,0)
 ;;=5^V70.7
 ;;^UTILITY(U,$J,358.3,620,2)
 ;;=^295597
 ;;^UTILITY(U,$J,358.3,621,0)
 ;;=V70.9^^6^79^11
 ;;^UTILITY(U,$J,358.3,621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,621,1,4,0)
 ;;=4^General Exam NOS
 ;;^UTILITY(U,$J,358.3,621,1,5,0)
 ;;=5^V70.9
 ;;^UTILITY(U,$J,358.3,621,2)
 ;;=^295602
 ;;^UTILITY(U,$J,358.3,622,0)
 ;;=998.00^^6^79^17
 ;;^UTILITY(U,$J,358.3,622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,622,1,4,0)
 ;;=4^Post-Op Shock NOS
 ;;^UTILITY(U,$J,358.3,622,1,5,0)
 ;;=5^998.00
 ;;^UTILITY(U,$J,358.3,622,2)
 ;;=^340612
 ;;^UTILITY(U,$J,358.3,623,0)
 ;;=998.02^^6^79^18
 ;;^UTILITY(U,$J,358.3,623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,623,1,4,0)
 ;;=4^Post-Op Shock,Septic
 ;;^UTILITY(U,$J,358.3,623,1,5,0)
 ;;=5^998.02
 ;;^UTILITY(U,$J,358.3,623,2)
 ;;=^340581
 ;;^UTILITY(U,$J,358.3,624,0)
 ;;=958.4^^6^79^19
 ;;^UTILITY(U,$J,358.3,624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,624,1,4,0)
 ;;=4^Traumatic Shock
 ;;^UTILITY(U,$J,358.3,624,1,5,0)
 ;;=5^958.4
 ;;^UTILITY(U,$J,358.3,624,2)
 ;;=^110195
 ;;^UTILITY(U,$J,358.3,625,0)
 ;;=995.0^^6^79^5
 ;;^UTILITY(U,$J,358.3,625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,625,1,4,0)
 ;;=4^Anaphylactic Shock
 ;;^UTILITY(U,$J,358.3,625,1,5,0)
 ;;=5^995.0
 ;;^UTILITY(U,$J,358.3,625,2)
 ;;=^340653
 ;;^UTILITY(U,$J,358.3,626,0)
 ;;=995.29^^6^79^2
 ;;^UTILITY(U,$J,358.3,626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,626,1,4,0)
 ;;=4^Adv Eff Drug NEC
 ;;^UTILITY(U,$J,358.3,626,1,5,0)
 ;;=5^995.29
 ;;^UTILITY(U,$J,358.3,626,2)
 ;;=^334181
 ;;^UTILITY(U,$J,358.3,627,0)
 ;;=V65.5^^6^79^10
 ;;^UTILITY(U,$J,358.3,627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,627,1,4,0)
 ;;=4^Feared Complaint No DX
 ;;^UTILITY(U,$J,358.3,627,1,5,0)
 ;;=5^V65.5
 ;;^UTILITY(U,$J,358.3,627,2)
 ;;=^295564
 ;;^UTILITY(U,$J,358.3,628,0)
 ;;=780.39^^6^79^7
 ;;^UTILITY(U,$J,358.3,628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,628,1,4,0)
 ;;=4^Convulsions Unspec
 ;;^UTILITY(U,$J,358.3,628,1,5,0)
 ;;=5^780.39
 ;;^UTILITY(U,$J,358.3,628,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,629,0)
 ;;=996.59^^6^79^13
 ;;^UTILITY(U,$J,358.3,629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,629,1,4,0)
 ;;=4^Mech Compl ET Tube
 ;;^UTILITY(U,$J,358.3,629,1,5,0)
 ;;=5^996.59
 ;;^UTILITY(U,$J,358.3,629,2)
 ;;=^276281
 ;;^UTILITY(U,$J,358.3,630,0)
 ;;=478.19^^6^79^15
 ;;^UTILITY(U,$J,358.3,630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,630,1,4,0)
 ;;=4^Nasal Sinus Disease
 ;;^UTILITY(U,$J,358.3,630,1,5,0)
 ;;=5^478.19
 ;;^UTILITY(U,$J,358.3,630,2)
 ;;=^334090
 ;;^UTILITY(U,$J,358.3,631,0)
 ;;=277.39^^6^79^4
